title: Chapter 9 - Nanoparticles influence pathophysiology of spinal cord injury and repair.
authors.affiliation: Laboratory of Cerebrovascular and Pain Research, Department of Surgical Sciences, Anesthesiology and Intensive Care Medicine, University Hospital, Uppsala University, SE-75185 Uppsala, Sweden. Sharma@surgsci.uu.se
authors.forename: Hari Shanker
authors.initials: HS
authors.lastname: Sharma
authors.forename: Dafin F
authors.initials: DF
authors.lastname: Muresanu
authors.forename: Aruna
authors.initials: A
authors.lastname: Sharma
authors.forename: Ranjana
authors.initials: R
authors.lastname: Patnaik
authors.forename: José Vicente
authors.initials: JV
authors.lastname: Lafuente
mesh_terms: D000818:Animals; D019610:Cytoprotection / Q000187:drug effects / Q000502:physiology; D016503:Drug Delivery Systems / Q000379:methods* / Q000639:trends; D006801:Humans; D053768:Metal Nanoparticles / Q000627:therapeutic use / Q000633:toxicity; D053758:Nanoparticles / Q000627:therapeutic use* / Q000633:toxicity; D036103:Nanotechnology / Q000379:methods* / Q000639:trends; D009410:Nerve Degeneration / Q000139:chemically induced / Q000503:physiopathology; D009462:Neurology / Q000379:methods* / Q000639:trends; D018696:Neuroprotective Agents / Q000008:administration & dosage; D018570:Risk Assessment; D013119:Spinal Cord Injuries / Q000188:drug therapy* / Q000503:physiopathology
chemical_list: D018696:Neuroprotective Agents